BC · Oncology · 12 drugs · 15 indications
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|---|---|---|---|---|
| Giredestrant | ROG.SW | SERD | Oral SERD | Oral | FILED |
| camizestrant | AZN | Oral SERD | Small molecule | ORAL | PHASE3 |
| Truqap | AZN | AKT inhibitor | Small molecule | ORAL | APPROVED |
| Enhertu | AZN, DSNKY | HER2-directed (DXd payload) | ADC | IV | APPROVED |
| Datroway | AZN, DSNKY | TROP2-directed (DXd payload) | ADC | IV | APPROVED |
| Verzenio | LLY | CDK4/6 inhibitor | Small molecule | ORAL | APPROVED |
| Kisqali | NVS | CDK4/6 inhibitor | Small molecule | Oral | APPROVED |
| Perjeta | ROG.SW | HER2 dimerization inhibitor | Antibody | IV | APPROVED |
| Herceptin | ROG.SW | HER2 antagonist | Antibody | IV/SC | APPROVED |
| Kadcyla | ROG.SW | HER2-targeted (DM1 payload) | ADC | IV | APPROVED |
| Phesgo | ROG.SW | HER2 dual blockade | Antibody | SC | APPROVED |
| Lynparza | AZN, MRK | PARP inhibitor | Small molecule | ORAL | APPROVED |